Pharmacy benefit

Following historical budget allocation, Canada enters BIO 2018 with thriving life science industry

June 6, 2018

Following historical budget allocation, Canada enters BIO 2018 with thriving life science industry Contact: Brendan Monahan Rasky Partners, Inc. bmonahan@rasky.com 413-537-4063 Boston, Ma (June 1st, 2018) –The size and prominence of the Canadian delegation arriving at BIO 2018 – among the largest international delegation – demonstrates the tremendous success that the government’s record setting investment […]

The Canadian Institute’s 4th Annual Pharma Symposium (June 13 – 14, 2018) in Toronto

May 17, 2018

Be a part of the discussion that determines the future of the industry at the 4th Annual Pharma Symposium returning June 13-14, 2018 to Toronto. Join manufacturers, regulators, payers and patient advocates to develop practical strategies for the market access and reimbursement sector. Understand plan design changes sponsors are undertaking to respond to cost pressures […]

Developing predominance of psychosis and associated diseases is driving the requirement for antipsychotic drugs.

April 26, 2018

Developing predominance of psychosis and associated diseases is driving the requirement for antipsychotic drugs. The main considerations contributing towards the developing rate of these diseases incorporate substance-induced psychoses, physical illness resulting in depression, and genetic mutations. The advent of more up to date antipsychotic compounds and immense speculations for R&D are boosting the market development. […]

Accumulator Adjustment Programs: What They Are and How Should a Brand Respond?

April 25, 2018

In a reported effort to reduce health plan spend for specialty drugs, pharmacy benefit managers have begun promoting “co-pay accumulator” programs to health plan sponsors. The effect of these programs is often to shift much of the cost burden for expensive specialty drugs toward patients and manufacturers. This white paper takes a deep dive into […]

RxTE Health Appoints Dave Teckman as Executive Chairman of the Board

February 13, 2018

Industry Veteran to Steer Pharmacy Benefit Solution Company’s Sales and Marketing Initiatives Sacramento, CA- February 13, 2018- RxTE Health (RxTE), a company specializing in pharmacy cost reduction programs for employers, today announced the appointment of Dave Teckman as Executive Chairman of the Board. In this role, Teckman will be responsible for overseeing business development, sales, […]

The California Co-Pay Conundrum

January 2, 2018

TrialCard Addresses AB 265 On October 9, 2017, California Governor Jerry Brown signed AB 265 into law. This landmark piece of legislation modified the California Health and Safety Code to prohibit the “offering” of any discount, product voucher, or other out-of-pocket cost reduction tool by drug manufacturers when there is an FDA-approved therapeutic equivalent. As […]

FEEDBACK